|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prophylactic quadrivalent human papillomavirus (types 6,11,16,and 18) L1 virus-like particle vaccine in young women:a randomised double-blind placebo -controlled multicentre phase Ⅱ efficacy trial显示文摘 | Villa LL Costa RL Petta CA | 2005 | Lancet Oncol2005，6，5： | 1 |
| 2 | High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up显示文摘 | Villa LL Costa RL Petta CA | 2006 | Br J Cancer2006，95，11： | 1 |
| 3 | Prophylactie quadrivalent hu- man papillomavirus(types 6,11,16, and 18) L1 virus - like particle vaccine in young women; A randomised double - blind placebo - controlled multicentre phase Ⅱ efficacy trial 显示文摘 | Villa LL Costa RL Petta CA | 2005 | Lancet Oncal2005，6，5： | 1 |
| 4 | High sustained efficacy of a prophylactic quadrivalent human papillomavims types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up 显示文摘 | Villa LL Costa RL Petta CA | 2006 | Br J Cancer2006，95，11： | 1 |
| 5 | Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) Llvirus-like particle vaccine in young women : a randomized double-blind placebo-controlled multicentre phase Ⅱ efficacy trial 显示文摘 | Villa LL Costa RL Petta CA | 2005 | Lancet Oneol2005，6，5： | 1 |
| 6 | Prophylactic quadrivalent human papillomavirns (types6,11,16,and 18) L1 virus-like particle vaccine in young women:a randomized double-blind placebocontrolled multicentre phase Ⅱ efficacy trial显示文摘 | Costa RL Petta CA | 2005 | The Lancet oncology2005，6，5： | 1 |
| 7 | Prophylactic quadrvalent human papillomavirus (type 6, 11, 16, and 18) LI virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial 显示文摘 | Villa LL Costa RL Petta CA | 2005 | Lancet Oneol2005，6，5： | 1 |
| 8 | High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18L1 virus-like particle vaccine through 5 years of follow-up显示文摘 | Villa LL Costa RL Petta CA | 2006 | Br J Cancer2006，95，11： | 1 |
| 9 | High sustained efficacy of a prophylactic quadrivalent Human papillomavirus types 6/11/16/18 Ll virus-like particle vaccine through 5 years of follow-up 显示文摘 | Villa LL Costa RL Petta CA | 2006 | Br J Cancer2006，95，： | 1 |
| 10 | Comparative evolutionary epi-demiology of dengue virus serotypes显示文摘 | Costa RL Voloch CM Schrago CG | 2012 | Infect Genet Evol2012，12，2： | 1 |
| 11 | Prophylactic quadrivalent human papillomavirus ( type6,11,16and18 ) L1 virus - like particle vaccine in young women:a randomized double -blind placebo- controlled multicentre phase Ⅱ efficacy tyial显示文摘 | Villa LL Costa RL Petta CA | 2005 | Lancet Oncal2005，6，5： | 1 |
| 12 | High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up显示文摘 | Villa LL Costa RL Petta CA | 2006 | Br J Cancer2006，95，11： | 1 |
| 13 | Prevalence of SCCmec type Ⅳ in nosocomial bloodstream isolates of methicillin-resistant Staphylococcus aureus 显示文摘 | de A Trindade P Pacheco RL Costa SF | 2005 | J Clin Microbiol2005，43，7： | 1 |
| 14 | Serum cytokines associated with severity and complications of kala-azar 显示文摘 | Costa DL Rocha RL Carvalho RM | 2013 | Pathog Glob Health2013，107，2： | 1 |
| 15 | Bone morphogenetic protein-2/4 and bone morphogenetic protein receptor type IA expression in metastatic and nonmetastatic oral squamous cell carcinoma显示文摘 | Soares AF Xavier RL da Costa Miguel MC | 2010 | Am J Otolaryngol2010，31，4： | 1 |
| 16 | High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/ 11/16/18 L1 virus-like particle vaccine through 5 years of follow-up显示文摘 | Villa LL Costa RL Petta CA | 2006 | Br J Cancer2006，95，11： | 1 |
| 17 | Prophy- lactic quadrivalenthuman papillomavirus (types6,11,16,and 18) L1 virus-like particle vaccine in young women:a randomised double-blind placebo-controlled multicentre phase II efficacy trial 显示文摘 | Villa LL Costa RL Petta CA | 2005 | Lancet Oncol2005，6，5： | 1 |
| 18 | Preventive and therapeutic anti-TNF-ct therapy with pentoxifylline decreases ar- thritis and the associated periodontal co-morbidity in mice 显示文摘 | Queiroz-Junior CM Bessoni RL Costa VV | 2013 | Life Sci2013，93，911： | 1 |
| 19 | Prophylactic quadrivalent human papillomavirus (types 6,11,16,and 18) L1 virus-like particle vaccine in young women:a randomised double-blind placebo-controlled multicentre phase II efficacy trial显示文摘 | Villa LL Costa RL Petta CA | 2005 | Lancet Oncol2005，6，5： | 1 |
| 20 | High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus - like particle vaccine through 5 years of follow - up显示文摘 | Villa LL Costa RL Petta CA | 2006 | BrJ Cancer2006，95，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员